United States · FDA National Drug Code directory
olopatadine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-861_d6814040-cbb9-4a23-aa29-e3d30bb97efc
- Product NDC
- 16571-861
- Form
- SOLUTION
- Composition / generic term
- olopatadine hydrochloride
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250501
- Source listing expiry
- 20261231
Source-listed ingredients
- OLOPATADINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CONTAINER in 1 CARTON (16571-861-25) / 2.5 mL in 1 CONTAINER · 16571-861-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →